市場調査レポート

商品コード

1562474

造影剤の市場規模、シェア、成長分析、タイプ別、形態別、モダリティ別、投与経路別、地域別 - 産業予測、2024年～2031年

Contrast Media Market Size, Share, Growth Analysis, By Type, By Form, By Modality, By Route of Administration, By Region - Industry Forecast 2024-2031

出版日: 2024年09月13日
発行: SkyQuest
ページ情報: 英文 260 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 760,921円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 890,134円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,019,347円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.57円

全表示
概要
目次

概要

サンプル依頼リストに入れる

世界の造影剤の市場規模は、2022年に61億米ドルとなり、2023年の65億5,000万米ドルから、2031年までには116億米ドルに成長し、予測期間中（2024年～2031年）のCAGRは7.4％で成長する見通しです。

複雑な併存疾患や慢性疾患の増加により、超音波、X線、MRI、CTスキャンなどの画像診断の利用が拡大しています。例えば、米国FDAは2019年11月に大環状MRI造影剤であるGEヘルスケアのクラリスカンを承認しました。こうした技術革新は、周術期のスキャンや介入の必要性を判断する上で極めて重要であり、市場拡大に寄与しています。National Health Councilによると、2019年には約8,100万人の米国人が複数の慢性疾患に罹患しており、これらの疾患の著しい蔓延が浮き彫りになっています。予測によると、近い将来、約1億5,700万人の米国人が慢性疾患の影響を受けることになります。慢性疾患は特に高齢者に多く、全米高齢化評議会によると、65歳以上の約80％が少なくとも1つの慢性疾患を抱えており、メディケア受給者の70％近くが複数の疾患を抱えています。2034年までに、約7,700万人のアメリカ人が65歳以上になると予想されています。さらに、米国における主要な死因である心不全は、ますます一般的になりつつあります。米国心臓協会の報告によると、2019年には約65万9,000人の米国人が心血管障害で死亡しており、心臓病の患者数は2031年までに46％増加すると予想されています。こうした動向は、予測期間中、世界市場における造影剤の需要を促進すると予想されます。

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2023年）
主要な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア（2023年）

主要企業プロファイル

GE Healthcare（US）
Bracco Imaging SpA（Italy）
Bayer AG（Germany）
Guerbet（France）
Lantheus Medical Imaging（US）
Unijules Life Sciences Ltd.（India）
J.B. Chemicals & Pharmaceuticals Limited（India）
Taejoon Pharm Co., Ltd.（South Korea）
Jodas Expoim（India）
Imax Diagnostic Imaging Limited（Ireland）
Yangtze River Pharmaceutical Group（China）
Livealth Biopharma（India）
Beijing Beilu Pharmaceutical Co., Ltd.（China）
Unispire Biopharma Private Limited（India）
Arco Lifesciences（I）Pvt. Ltd.（India）
Stanex Drugs & Chemicals Pvt. Ltd.（India）
Rege Imaging & Cine Films Private Limited（India）
K Diam Exim（India）
Onko Ilac San. ve Tic. A.S.（Turkey）
Fresenius Kabi（Germany）
Biem Ilac San. ve Tic. A.S.（Turkey）
Advacare Pharma（US）

Product Code: SQMIG35B2070

Global Contrast Media Market size was valued at USD 6.10 billion in 2022 and is poised to grow from USD 6.55 billion in 2023 to USD 11.60 billion by 2031, growing at a CAGR of 7.4% during the forecast period (2024-2031).

The increasing prevalence of complex comorbidities and chronic illnesses is driving the growing use of diagnostic imaging procedures, including ultrasound, X-rays, MRI, and CT scans. For instance, the U.S. FDA approved GE Healthcare's Clariscan, a macrocyclic MRI contrast agent, in November 2019. Such innovations are crucial for determining the need for perioperative scans and interventions, contributing to market expansion. According to the National Health Council, approximately 81 million Americans had multiple chronic conditions in 2019, highlighting the significant prevalence of these diseases. Projections suggest that nearly 157 million Americans will be affected by chronic illnesses in the near future. Chronic diseases are particularly prevalent among older adults, with about 80% of individuals aged 65 and older having at least one chronic illness, and nearly 70% of Medicare recipients managing multiple conditions, according to the National Council on Aging. By 2034, it is anticipated that approximately 77 million Americans will be 65 or older. Additionally, heart failure, a major cause of death in the U.S., is becoming increasingly common. The American Heart Association reports that around 659,000 Americans died from cardiovascular disorders in 2019, and the number of heart disease cases is expected to rise by 46% by 2031. These trends are expected to drive the demand for contrast media in the global market over the forecast period.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Contrast Media market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Contrast Media Market Segmental Analysis

Global Contrast Media Market is segmented by Type, Form, Modality, Route of Administration, Indication, Application, End User, and region. Based on Type, the market is segmented into Iodinated Contrast Media, Gadolinium-based Contrast Media, Microbubble Contrast Media, and Barium-based Contrast Media. Based on Form, the market is segmented into Liquid Contrast Media, Powder Contrast Media, and Other Forms. Based on Modality, the market is segmented into X-RAY, CT, MRI, and Ultrasound. Based on Route of Administration, the market is segmented into Intravascular Route [Intravenous (IV) route, Intra-arterial (IA) route], Oral Route, Rectal Route, and Other Routes. Based on Indication, the market is segmented into Cardiovascular Disease, Cancer, Gastrointestinal Disorders, Musculoskeletal Disorders, Neurological Disorders, and Nephrological Disorders. Based on Application, the market is segmented into Radiology, Interventional Radiology, and Interventional Cardiology. Based on End User, the market is segmented into Hospitals, Clinics, And Ambulatory Surgery Centers, and Diagnostic Imaging Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Contrast Media Market

The global rise in chronic illnesses has led to a substantial increase in the demand for diagnostic imaging procedures and, by extension, contrast media. To address this growing need and to gain approval for new indications, manufacturers of contrast media have been heavily investing in research and development. This investment aims to bring innovative products to the market and enhance their existing offerings. For example, the US FDA approved a new 20-vial pack design of the ultrasound contrast agent Lumason for use by Bracco. This approval reflects the industry's efforts to meet the increasing demand for advanced imaging solutions and to provide healthcare professionals with more effective tools for diagnosing and managing chronic conditions.

Restraints in the Global Contrast Media Market

Contrast agents are widely utilized in various diagnostic techniques, such as MRI and CT scans, due to their ability to enhance imaging clarity. However, the market's growth may be somewhat limited by the potential for adverse effects and allergic reactions associated with their use. Although these negative reactions can vary from mild to severe, it is important to note that severe and major allergic responses are relatively rare.

Market Trends of the Global Contrast Media Market

Iodinated contrast medium is a type of intravenous radiocontrast used to enhance the visibility of vascular systems and organs during radiographic procedures. This contrast medium has been instrumental in detecting conditions such as cancer by improving imaging clarity. The current iodinated contrast media are developed from chemically modified tri-iodinated benzene rings. The effectiveness of iodinated contrast media in attenuating X-rays is influenced by the amount of iodine present in the tissue being imaged, with this attenuation being inversely related to the X-ray energy used. Consequently, the selection and quantity of contrast media needed for specific imaging tasks are based on the desired imaging quality.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Value Chain Analysis
Ecosystem of the Market
Trade Analysis
Supply chain Analysis
Case study Analysis
Patent Analysis
Customer & Buying Criteria Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Contrast Media Market by Type

Market Overview
Iodinated Contrast Media
Gadolinium-based Contrast Media
Microbubble Contrast Media
Barium-based Contrast Media

Contrast Media Market by Form

Market Overview
Liquid Contrast Media
Powder Contrast Media
Other Forms

Contrast Media Market by Modality

Market Overview
X-RAY
CT
MRI
Ultrasound

Contrast Media Market by Route of Administration

Market Overview
Intravascular Route
- Intravenous (IV) route
- Intra-arterial (IA) route
Oral Route
Rectal Route
Other Routes

Contrast Media Market by Indication

Market Overview
Cardiovascular Disease
Cancer
Gastrointestinal Disorders
Musculoskeletal Disorders
Neurological Disorders
Nephrological Disorders

Contrast Media Market by Application

Market Overview
Radiology
Interventional Radiology
Interventional Cardiology

Contrast Media Market by End User

Market Overview
Hospitals, Clinics, And Ambulatory Surgery Centers
Diagnostic Imaging Centers

Contrast Media Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

GE Healthcare (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bracco Imaging SpA (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Guerbet (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lantheus Medical Imaging (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Unijules Life Sciences Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
J.B. Chemicals & Pharmaceuticals Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Taejoon Pharm Co., Ltd. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jodas Expoim (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Imax Diagnostic Imaging Limited (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Yangtze River Pharmaceutical Group (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Livealth Biopharma (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beijing Beilu Pharmaceutical Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Unispire Biopharma Private Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Arco Lifesciences (I) Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stanex Drugs & Chemicals Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Rege Imaging & Cine Films Private Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
K Diam Exim (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Onko Ilac San. ve Tic. A.S. (Turkey)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fresenius Kabi (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biem Ilac San. ve Tic. A.S. (Turkey)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Advacare Pharma (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

造影剤の市場規模、シェア、成長分析、タイプ別、形態別、モダリティ別、投与経路別、地域別 - 産業予測、2024年～2031年

Contrast Media Market Size, Share, Growth Analysis, By Type, By Form, By Modality, By Route of Administration, By Region - Industry Forecast 2024-2031

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主要な市場の考察

造影剤市場：タイプ別

造影剤市場：形態別

造影剤市場：モダリティ別

造影剤市場：投与経路別

造影剤市場：適応症別

造影剤市場：用途別

造影剤市場：エンドユーザー別

造影剤市場規模：地域別